@ARTICLE{
author={Miletic Dragana,Kraljevic Marija,Sokolovic Emir,Soce Majana,Milovic-Kovacevic Marijana M,Bobic Simonida,Ceric Timur,Plestina Stjepko,Beslija Semir,Marijanovic Inga},
year={2023},
title={Differences in Outcomes Between Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Metastatic Breast Cancer Patients in Upper Middle-Income versus High-Income Countries: A Retrospective Study from 4 Oncology Centers},
journal={MEDICAL SCIENCE MONITOR},
volume={29},
number={},
pages={-},
document_type={Article},
} 

@ARTICLE{
author={Andric Zoran G,Ceric Timur,Rancic Milan H,Jakopovic Marko,Aix S Ponce,Ramlau Rodryg,Ulanska M,Caldwell C,Ferrari D,Annis A,Vukovic V,Zaric Bojan},
year={2021},
title={A phase Ib/II study of the dual MDMX/MDM2 inhibitor, ALRN-6924, for the prevention of chemotherapy-induced myelosuppression},
journal={ANNALS OF ONCOLOGY},
volume={32},
number={},
pages={S1166-S1166},
document_type={Meeting Abstract},
} 

@ARTICLE{
author={Andric Zoran G,Ceric Timur,Stanetic Mirko,Rancic Milan H,Jakopovic Marko,Aix S Ponce,Ramlau Rodryg,Smit E,Ulanska M,Caldwell C,Ferrari D,Annis A,Vukovic V,Zaric Bojan},
year={2020},
title={Prevention of Chemotherapy-induced Myelosuppression in SCLC patients treated with the Dual MDMX/MDM2 Inhibitor ALRN-6924},
journal={EUROPEAN JOURNAL OF CANCER},
volume={138},
number={},
pages={S5-S5},
document_type={Meeting Abstract},
} 

@ARTICLE{
author={Todorovic Vladimir,...,Babovic Nada Lj,...,Cetnikovic Bojana,Ceric Timur,...,Dzamic Zoran M,Dzodic Radan R,Eri Zivka,...,Knezevic-Usaj Slavica F,Kovcin Vladimir N,...,Markovic Ivan Z,Markovic Milan,Mijalkovic Nenad,...,Pantelic Aleksandra,Popovic Lazar S,Radosavljevic Davorin Z,...,Radulovic Sinisa S,...,Rosic Ivana,...,Stamatovic Ljiljana,...,Tesanovic Dusanka D,Tomasevic Zorica I,Tomasevic Zoran M,...,Vasovic Suzana,Vicko Ferenc,...,Zaric Bojan,...,(broj koautora 65)},
year={2019},
title={AROME-ESO Oncology Consensus Conference: access to cancer care innovations in countries with limited resources. Association of Radiotherapy and Oncology of the Mediterranean Area (AROME-Paris) and European School of Oncology (ESO - Milan)},
journal={JOURNAL OF BUON},
volume={24},
number={5},
pages={2180-2197},
document_type={Article},
} 

@ARTICLE{
author={Ramalingam Suresh S,Zaric Bojan,Ceric Timur,...,Samarzija Miroslav,...,Vukovic Vojislav M,(broj koautora 20)},
year={2014},
title={Galaxy-2 trial (NCT01798485): A randomized phase 3 study of ganetespib itt combination with docetaxel versus docetaxel alone in patients with advanced lung adenocarcinoma.},
journal={JOURNAL OF CLINICAL ONCOLOGY},
volume={32},
number={15},
pages={-},
document_type={Meeting Abstract},
} 

@ARTICLE{
author={Ramalingam Suresh S,...,Andric Zoran G,...,Zaric Bojan,Ceric Timur,...,Vukovic Vojislav M,...,(broj koautora 20)},
year={2013},
title={A randomized study of ganetespib, a heat shock protein 90 inhibitor, in combination with docetaxel versus docetaxel alone for second-line therapy of lung adenocarcinoma (GALAXY-1)},
journal={JOURNAL OF CLINICAL ONCOLOGY},
volume={31},
number={15},
pages={-},
document_type={Meeting Abstract},
} 

@ARTICLE{
author={Fennell DA,Goss GD,Andric Zoran G,Bondarenko Igor N,Zaric Bojan,Ceric Timur,Poddubskaya Elena,Teofilovici F,Guo W,Ramalingam Suresh S},
year={2013},
title={Ganetespib in combination with docetaxel versus docetaxel alone in second line adenocarcinoma patients with KRAS mutations and elevated LDH levels},
journal={EUROPEAN JOURNAL OF CANCER},
volume={49},
number={},
pages={S801-S801},
document_type={Meeting Abstract},
} 

@ARTICLE{
author={Andric Zoran G,Havel L,Di Hariry I,Vukovic Vojislav M,Teofilovici F,Guo W,Mulcahey S,Bradley R,Ceric Timur},
year={2012},
title={Quality of Life Analysis in the Galaxy Trialtm (Nct01348126): a Randomized Phase Iib/Iii Study of Ganetespib (Sta-9090) in Combination with Docetaxel Versus Docetaxel Alone in Patients with Stage Iiib Or Iv Nsclc},
journal={ANNALS OF ONCOLOGY},
volume={23},
number={},
pages={436-436},
document_type={Meeting Abstract},
}